Its technology.
The Layer 7 Cortical Interface is an ultra-thin and flexible implant that is placed on the surface of the brain, this device uses electrodes to map and stimulate brain activities with exceptional precision, Layer 7 Cortical Interface is so thin that it is barely one-fifth the thickness of a human hair.
Its implantation method is based on micro incisions of only 400 microns in the skull, eliminating the need for large openings or craniotomies, this drastically reduces surgical risks, speeding up recovery and improving safety for patients with delicate conditions, such as spinal injuries. spinal.
With 1024 electrodes the ion chip captures and transmits brain signals in high resolution interpreting different volumes of information in real time, to put it in perspective while Neuralink has performed only two implants in humans in its 9 years of existence and another competing company cycron achieved eight in 12 years; Precision Neuros Science completed 26 procedures in just 3 years highlighting the efficiency and potential of their approach.
Additionally, the company has reported positive results in pilot studies, in some trials the implants were inserted and removed after only 15 minutes demonstrating the simplicity and safety of the process.
New applications.
The flexible and reversible design of the device allows adjustments or removal without damaging brain tissue. Today, brain implants are widely used to treat conditions such as severe epilepsy, movement disorders such as Parkinson's and obsessive-compulsive disorder. However, new ones are rapidly emerging. applications.
Studies indicate that these devices can restore speech in patients with locked-in syndrome, restore sight to blind people and even recover movement in paralyzed patients, but the advances do not end there, brain-computer interfaces have the potential to treat complex psychiatric conditions. such as “depression and eating disorders.”
“We know this works,” said Dr. Ben Rapoport, co-founder of Precision Neuros Science and surgeon at Mount Sinai Hospital in New York. The challenge now is to refine the engineering details to create durable, high-resolution devices. He also highlighted that The advancement of technologies such as 5G, Bluetooth and microfabrication are accelerating the path for these innovations to reach the market.
The company is focused on treating spinal cord injuries, strokes and amyotrophic lateral sclerosis, with a potential target audience of an estimated 400,000 patients in the United States alone.
Technology promises to redefine what is possible and the interaction between biology and technology.
